• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在膀胱癌膀胱切除术标本中,全器官包埋可提高组织病理学参数的检出率,但对具有预后意义的参数则不然。

In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.

作者信息

Gaisa Nadine T, Wilms Holger, Wild Peter J, Jakse Gerhard, Heidenreich Axel, Knuechel Ruth

机构信息

Institute of Pathology, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.

出版信息

Virchows Arch. 2015 Apr;466(4):423-32. doi: 10.1007/s00428-015-1726-7. Epub 2015 Feb 13.

DOI:10.1007/s00428-015-1726-7
PMID:25677977
Abstract

Histological tumor subtyping, staging, and grading are of utmost importance to stratify patients with bladder cancer for treatment and should be as precise as possible. In the presented study, we investigated the prognostic impact of standard clinicopathological parameters in cystectomy patients and compared embedding of the entire bladder with standard partial embedding via a virtual superimposed approach. The study included 121 cystectomy specimens, which were completely embedded. Clinical and histopathological data of patients were obtained (median follow-up 21.5 months; range 1-67 months). For 88 patients two-dimensional tumor maps (macrophotographs and histology-based maps) were prepared, and embedding of the entire bladder was compared with a virtual standard partial embedding, created by a virtual overlay and data extraction of the tumor maps. Kaplan-Meier plots, Cox regression estimators, Chi-square, and McNemar tests were used. In a multivariate Cox regression model for overall survival, only venous invasion (p = 0.008, HR = 3.35, 95 % CI 1.375-8.161) and organ-confined (pTis-pT2) versus non-organ-confined diseases (pT3-pT4; p = 0.021, HR 2.669, 95 % CI 1.157-6.159) were found significant. Advanced versus standard embedding revealed significant improvement in the detection of carcinoma in situ (50 versus 61, p = 0.003) and lymphatic invasion (18 versus 24, p = 0.041), but no significant advantage in the detection of tumor stage, tumor multifocality, or venous invasion (all p > 0.05). TNM classification, including lymphatic and venous invasion, is of utmost importance to stratify patients with advanced invasive bladder cancer. Histopathological details are detected more reliably by whole organ embedding, but this approach showed no significant benefit in terms of outcome-related parameters (max. tumor stage, venous invasion) in our cohort.

摘要

组织学肿瘤亚型分类、分期和分级对于膀胱癌患者的治疗分层至关重要,且应尽可能精确。在本研究中,我们调查了膀胱切除患者标准临床病理参数的预后影响,并通过虚拟叠加方法比较了整个膀胱包埋与标准部分包埋。该研究纳入了121个完全包埋的膀胱切除标本。获取了患者的临床和组织病理学数据(中位随访时间21.5个月;范围1 - 67个月)。为88例患者制备了二维肿瘤图谱(大体照片和基于组织学的图谱),并将整个膀胱的包埋与通过虚拟叠加和肿瘤图谱数据提取创建的虚拟标准部分包埋进行比较。使用了Kaplan - Meier曲线、Cox回归估计、卡方检验和McNemar检验。在多变量Cox回归模型中,对于总生存期,仅发现静脉侵犯(p = 0.008,HR = 3.35,95% CI 1.375 - 8.161)以及器官局限性(pTis - pT2)与非器官局限性疾病(pT3 - pT4;p = 0.021,HR 2.669,95% CI 1.157 - 6.159)具有显著性。与标准包埋相比,先进包埋在原位癌(50对61,p = 0.003)和淋巴侵犯(18对24,p = 0.041)的检测方面有显著改善,但在肿瘤分期、肿瘤多灶性或静脉侵犯的检测方面无显著优势(所有p > 0.05)。包括淋巴和静脉侵犯的TNM分类对于晚期浸润性膀胱癌患者的分层至关重要。通过全器官包埋能更可靠地检测到组织病理学细节,但在我们的队列中,这种方法在与预后相关的参数(最大肿瘤分期、静脉侵犯)方面未显示出显著益处。

相似文献

1
In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.在膀胱癌膀胱切除术标本中,全器官包埋可提高组织病理学参数的检出率,但对具有预后意义的参数则不然。
Virchows Arch. 2015 Apr;466(4):423-32. doi: 10.1007/s00428-015-1726-7. Epub 2015 Feb 13.
2
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
3
Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.膀胱尿路上皮移行细胞癌中,肌肉浸润诊断与根治性膀胱切除术之间的时间间隔对预后的意义。
Scand J Urol Nephrol. 2004;38(3):231-5. doi: 10.1080/00365590410029141.
4
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.
5
[A clinicopathological study on patients with bladder cancer treated with cystectomy].[膀胱癌患者膀胱切除术的临床病理研究]
Hinyokika Kiyo. 1990 Oct;36(10):1149-54.
6
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.在根治性膀胱切除术的 pT1 尿路上皮癌患者中,联合免疫组化标志物的预测价值。
J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17.
7
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.鳞状和腺体分化对膀胱癌根治性膀胱切除术后生存的影响。
J Urol. 2012 Aug;188(2):405-9. doi: 10.1016/j.juro.2012.04.020. Epub 2012 Jun 14.
8
Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.前列腺累及尿路上皮癌:肿瘤分期修订和合并膀胱癌与根治性膀胱切除术生存的相关性。
BJU Int. 2014 Dec;114(6):832-6. doi: 10.1111/bju.12486.
9
Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.首次就诊时根据膀胱癌肿瘤分期的根治性膀胱切除术后生存率。
Urol Int. 2004;72(2):103-11. doi: 10.1159/000075962.
10
Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.微乳头型尿路上皮癌变异组织学对根治性膀胱切除术后生存的影响。
Urol Oncol. 2014 Feb;32(2):110-6. doi: 10.1016/j.urolonc.2012.04.020. Epub 2013 Mar 14.

引用本文的文献

1
The Handling and Sampling of Radical Cystectomy Specimens: A Standardized Approach for Pathological Evaluation.根治性膀胱切除术标本的处理与取样:病理评估的标准化方法
Methods Protoc. 2025 Apr 5;8(2):35. doi: 10.3390/mps8020035.
2
Variation in cystectomy pathology reporting practice-results from an international survey of 212 pathologists.膀胱切除术病理报告实践的变化——来自对 212 名病理学家的国际调查结果。
Virchows Arch. 2024 Nov;485(5):879-888. doi: 10.1007/s00428-024-03924-3. Epub 2024 Sep 7.
3
Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.

本文引用的文献

1
Presence of lymphovascular invasion in urothelial bladder cancer specimens after transurethral resections correlates with risk of upstaging and survival: a systematic review and meta-analysis.经尿道切除术后尿路上皮膀胱癌标本中淋巴管浸润的存在与分期升级风险及生存率相关:一项系统评价和荟萃分析。
Urol Oncol. 2014 Nov;32(8):1191-9. doi: 10.1016/j.urolonc.2014.05.008. Epub 2014 Jun 20.
2
Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy.采用根治性膀胱切除术大体解剖方案准确确定病理分期。
Pathol Oncol Res. 2014 Jul;20(3):677-85. doi: 10.1007/s12253-014-9748-z. Epub 2014 Feb 23.
3
根治性膀胱切除术后伴原位癌的膀胱癌患者预后可能不是一个预后因素:一项符合 PRISMA 原则的系统评价和荟萃分析。
World J Urol. 2020 Jan;38(1):129-142. doi: 10.1007/s00345-019-02738-2. Epub 2019 Mar 27.
4
[Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].[从病理学角度看肿瘤发生:膀胱癌中的肿瘤扩散及表观遗传调控基因]
Pathologe. 2016 Nov;37(Suppl 2):196-203. doi: 10.1007/s00292-016-0207-3.
5
What can be more prognostic than the pTNM category assessed on radical cystectomy specimens?有什么比根治性膀胱切除标本上评估的pTNM分类更具预后价值呢?
Virchows Arch. 2015 Oct;467(4):481-2. doi: 10.1007/s00428-015-1831-7. Epub 2015 Aug 23.
6
Response letter to "What can be more prognostic than the pTNM category assessed in radical cystectomy samples?" by Sükösd F, Ivanyi B and Pajor L.对Sükösd F、Ivanyi B和Pajor L所著《在根治性膀胱切除术样本中评估的pTNM分类之外,还有什么更具预后价值?》的回复信
Virchows Arch. 2015 Oct;467(4):483-4. doi: 10.1007/s00428-015-1835-3. Epub 2015 Aug 21.
Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen.
根治性膀胱切除标本中 pT0/pT1/pTa 期患者的预后因素。
Arch Esp Urol. 2013 Oct;66(8):787-95.
4
Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.优化根治性膀胱切除术前新辅助化疗的患者选择。
J Urol. 2014 Jan;191(1):40-7. doi: 10.1016/j.juro.2013.07.061. Epub 2013 Jul 30.
5
Precise morphologic documentation with large-format histology of clinical findings in a bladder cancer patient.对一名膀胱癌患者的临床发现进行大幅面组织学的精确形态学记录。
Eur Urol. 2013 Sep;64(3):519-21. doi: 10.1016/j.eururo.2013.06.001. Epub 2013 Jun 12.
6
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.膀胱尿路上皮癌在膀胱切除标本中出现鳞状和腺性分化是否预示预后不良?一项深入的病例对照分析。
Urol Oncol. 2014 Feb;32(2):117-27. doi: 10.1016/j.urolonc.2012.08.017. Epub 2013 Mar 7.
7
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.根治性膀胱切除术治疗膀胱癌患者的组织学亚型对肿瘤学结局的影响。
Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4.
8
Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.脉管浸润与根治性膀胱切除术后病理分期为 T1 且淋巴结阴性的患者膀胱癌复发和生存独立相关。
BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26.
9
A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens.膀胱癌病理标准的当代更新:经尿道切除和根治性膀胱切除术标本。
Eur Urol. 2013 Feb;63(2):321-32. doi: 10.1016/j.eururo.2012.10.008. Epub 2012 Oct 12.
10
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.根治性膀胱切除术治疗淋巴结阳性尿路上皮癌后淋巴结周围淋巴管血管侵犯的预后价值。
Eur Urol. 2013 Apr;63(4):739-44. doi: 10.1016/j.eururo.2012.09.053. Epub 2012 Sep 28.